BMS-354825

What BMS-354825 Means in Everyday Medical Language

BMS-354825 is the scientific or research name for a medicine more commonly called dasatinib, with the brand name Sprycel. It is a type of targeted therapy known as a tyrosine kinase inhibitor. This means it works by blocking specific proteins inside cancer cells, such as BCR-ABL1, that send signals telling the cells to grow and divide. By blocking these signals, dasatinib helps slow or stop the growth of certain leukemia cells.

Why BMS-354825 Can Matter in Cancer Care

Dasatinib is mainly used to treat chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL) when the cancer cells have a genetic change called the Philadelphia chromosome. This genetic change creates an abnormal protein that helps cancer cells grow. Dasatinib targets this protein, making it an important option for patients with these types of leukemia. It can be used alone or with other chemotherapy drugs, especially when other treatments have not worked or cannot be given.

What Patients Might See or Hear About BMS-354825

You might hear the terms BMS-354825, dasatinib, or Sprycel during your diagnosis, treatment discussions, or when considering clinical trials. These names all refer to the same medicine. You may see these terms in your medical records, treatment plans, or drug information sheets. Because the names differ, it’s helpful to ask your healthcare team which name they are using and what it means for your care.

Common Questions to Ask Your Care Team

When discussing dasatinib, you might ask how it works for your type of leukemia, what side effects to watch for, how the drug will be given, and how long treatment might last. You can also ask if there are clinical trials involving dasatinib that you might consider. Understanding these points can help you feel more confident and involved in your care.

What BMS-354825 Does Not Automatically Mean

Seeing the name BMS-354825 or dasatinib does not mean this drug is a cure or that it is suitable for every patient. It is specifically used for certain leukemias with the Philadelphia chromosome and may not be effective or safe for other cancers or patients without this genetic change. Side effects and drug interactions are possible, so close communication with your healthcare team is essential.

How to Use This Information Safely

This information is meant to help you understand what BMS-354825 (dasatinib) is and how it might fit into cancer treatment. It is educational and does not replace personalized medical advice. Your healthcare providers know your specific situation best and will guide you on whether this drug is appropriate for you. If you see this term in your records or hear it during visits, use it as a starting point to ask questions and learn more about your treatment options.

Next Steps for Patients and Caregivers

If you want to learn more about dasatinib, talk openly with your doctor, nurse, or pharmacist. They can explain how this medicine fits your treatment plan, what benefits and risks it may have, and how to manage any side effects. Staying informed and involved helps you make the best decisions for your health and care.